ImmuCell Current Ratio 2010-2023 | ICCC
ImmuCell current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| ImmuCell Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.01B | $0.00B | 2.73 |
| 2023-09-30 | $0.01B | $0.00B | 3.59 |
| 2023-06-30 | $0.01B | $0.00B | 2.61 |
| 2023-03-31 | $0.01B | $0.00B | 3.19 |
| 2022-12-31 | $0.01B | $0.00B | 4.56 |
| 2022-09-30 | $0.02B | $0.00B | 6.05 |
| 2022-06-30 | $0.02B | $0.00B | 6.34 |
| 2022-03-31 | $0.02B | $0.00B | 7.11 |
| 2021-12-31 | $0.02B | $0.00B | 6.42 |
| 2021-09-30 | $0.02B | $0.00B | 7.42 |
| 2021-06-30 | $0.02B | $0.00B | 7.64 |
| 2021-03-31 | $0.01B | $0.00B | 5.63 |
| 2020-12-31 | $0.01B | $0.00B | 5.50 |
| 2020-09-30 | $0.01B | $0.00B | 5.52 |
| 2020-06-30 | $0.01B | $0.00B | 4.77 |
| 2020-03-31 | $0.01B | $0.00B | 5.88 |
| 2019-12-31 | $0.01B | $0.00B | 5.29 |
| 2019-09-30 | $0.01B | $0.00B | 6.12 |
| 2019-06-30 | $0.01B | $0.00B | 8.22 |
| 2019-03-31 | $0.02B | $0.00B | 7.26 |
| 2018-12-31 | $0.01B | $0.00B | 2.50 |
| 2018-09-30 | $0.01B | $0.00B | 3.23 |
| 2018-06-30 | $0.01B | $0.00B | 4.25 |
| 2018-03-31 | $0.01B | $0.00B | 4.54 |
| 2017-12-31 | $0.01B | $0.00B | 3.64 |
| 2017-09-30 | $0.01B | $0.00B | 1.75 |
| 2017-06-30 | $0.01B | $0.00B | 1.89 |
| 2017-03-31 | $0.01B | $0.00B | 6.19 |
| 2016-12-31 | $0.01B | $0.00B | 6.97 |
| 2016-09-30 | $0.01B | $0.00B | 12.09 |
| 2016-06-30 | $0.01B | $0.00B | 11.92 |
| 2016-03-31 | $0.01B | $0.00B | 14.88 |
| 2015-12-31 | $0.01B | $0.00B | 9.94 |
| 2015-09-30 | $0.01B | $0.00B | 12.04 |
| 2015-06-30 | $0.01B | $0.00B | 9.65 |
| 2015-03-31 | $0.01B | $0.00B | 8.09 |
| 2014-12-31 | $0.01B | $0.00B | 5.42 |
| 2014-09-30 | $0.01B | $0.00B | 7.39 |
| 2014-06-30 | $0.01B | $0.00B | 7.64 |
| 2014-03-31 | $0.01B | $0.00B | 8.09 |
| 2013-12-31 | $0.01B | $0.00B | 11.43 |
| 2013-09-30 | $0.01B | $0.00B | 13.67 |
| 2013-06-30 | $0.01B | $0.00B | 8.96 |
| 2013-03-31 | $0.01B | $0.00B | 13.11 |
| 2012-12-31 | $0.01B | $0.00B | 11.06 |
| 2012-09-30 | $0.01B | $0.00B | 13.22 |
| 2012-06-30 | $0.01B | $0.00B | 14.00 |
| 2012-03-31 | $0.01B | $0.00B | 11.56 |
| 2011-12-31 | $0.01B | $0.00B | 11.26 |
| 2011-09-30 | $0.01B | $0.00B | 11.82 |
| 2011-06-30 | $0.01B | $0.00B | 8.42 |
| 2011-03-31 | $0.01B | $0.00B | 10.30 |
| 2010-12-31 | $0.01B | $0.00B | 13.39 |
| 2010-09-30 | $0.01B | $0.00B | 16.83 |
| 2010-06-30 | $0.01B | $0.00B | 19.66 |
| 2010-03-31 | $0.01B | $0.00B | 17.03 |
| 2009-12-31 | $0.01B | $0.00B | 17.50 |
| 2009-09-30 | $0.01B | $0.00B | 23.56 |
| 2009-06-30 | $0.01B | $0.00B | 16.87 |
| 2009-03-31 | $0.01B | $0.00B | 14.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.040B | $0.017B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.775B | 24.06 |
| Stryker (SYK) | United States | $123.999B | 29.70 |
| Medtronic (MDT) | Ireland | $108.563B | 15.37 |
| Boston Scientific (BSX) | United States | $106.438B | 33.90 |
| EssilorLuxottica (ESLOY) | France | $97.377B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.685B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
| ResMed (RMD) | United States | $31.870B | 29.92 |
| Terumo (TRUMY) | Japan | $26.117B | 36.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.962B | 19.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.803B | 15.84 |
| Baxter (BAX) | United States | $18.605B | 13.23 |
| Insulet (PODD) | United States | $12.352B | 64.85 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.041B | 23.96 |
| BellRing Brands (BRBR) | United States | $7.489B | 35.08 |
| Lantheus Holdings (LNTH) | United States | $5.234B | 13.04 |
| Haemonetics (HAE) | United States | $4.844B | 24.77 |
| Perrigo (PRGO) | Ireland | $4.530B | 12.96 |
| GN Store Nord (GNNDY) | Denmark | $4.368B | 24.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.43 |
| Envista Holdings (NVST) | United States | $3.276B | 13.52 |
| QuidelOrtho (QDEL) | United States | $2.903B | 10.54 |
| Green Thumb Industries (GTBIF) | United States | $2.634B | 83.47 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| TG Therapeutics (TGTX) | United States | $2.552B | 71.78 |
| ICU Medical (ICUI) | United States | $2.454B | 18.31 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.265B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.886B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.786B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.683B | 49.34 |
| InMode (INMD) | Israel | $1.566B | 8.33 |
| Owens & Minor (OMI) | United States | $1.470B | 12.81 |
| National Vision Holdings (EYE) | United States | $1.431B | 44.56 |
| AdaptHealth (AHCO) | United States | $1.409B | 10.60 |
| Warby Parker (WRBY) | United States | $1.268B | 0.00 |
| AtriCure (ATRC) | United States | $1.052B | 0.00 |
| MacroGenics (MGNX) | United States | $1.024B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.985B | 0.00 |
| Evolus (EOLS) | United States | $0.838B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.822B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.666B | 14.43 |
| Quanterix (QTRX) | United States | $0.643B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.03 |
| Jin Medical (ZJYL) | China | $0.560B | 0.00 |
| Valneva SE (VALN) | France | $0.522B | 0.00 |
| PetIQ (PETQ) | United States | $0.519B | 19.40 |
| TerrAscend (TSNDF) | Canada | $0.501B | 0.00 |
| Surmodics (SRDX) | United States | $0.463B | 29.00 |
| Biote (BTMD) | United States | $0.452B | 4.30 |
| ZimVie (ZIMV) | United States | $0.431B | 26.37 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Aurora Cannabis (ACB) | Canada | $0.362B | 0.00 |
| Zynex (ZYXI) | United States | $0.341B | 46.70 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.319B | 31.61 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.257B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.42 |
| Veru (VERU) | United States | $0.240B | 0.00 |
| Omeros (OMER) | United States | $0.213B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.202B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.167B | 0.00 |
| InterCure (INCR) | Israel | $0.165B | 27.85 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 71.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 20.44 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.57 |
| MariMed (MRMD) | United States | $0.109B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 0.00 |
| Brainsway (BWAY) | Israel | $0.096B | 0.00 |
| Chimerix (CMRX) | United States | $0.090B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.067B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.87 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.50 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |